Turkiye Klinikleri Journal of Nursing Sciences

.: REVIEW
Periferik Venöz Katetere Bağlı Flebit Gelişiminin Önlenmesinde Kanıta Dayalı Hemşirelik Uygulamaları: Geleneksel Derleme
Evidence Based Nursing Practices in Preventing the Development of Phlebits Due to Peripheral Venous Catheter: Traditional Review
Tuğba DOSTa , Nuran TOSUNb
aKaramanoğlu Mehmetbey Üniversitesi Teknik Bilimler Meslek Yüksekokulu, Bitkisel ve Hayvansal Üretim Bölümü, Karaman, Türkiye
bHasan Kalyoncu Üniversitesi Sağlık Bilimleri Fakültesi, Hemşirelik Fakültesi, Gaziantep, Türkiye
Turkiye Klinikleri J Nurs Sci. 2023;15(4):1207-16
doi: 10.5336/nurses.2023-97915
Article Language: TR
Full Text
ÖZET
Hastanın derisi yoluyla damar lümeni içerisine kanül yerleştirilmesi işlemi olan periferik venöz kateterizasyon (PVK), hastanede yatarak tedavi olan hastalarda en sık uygulanan invaziv hemşirelik girişimlerinden birisidir. PVK doğru şekilde uygulandığında yararlı ve hastanın hayatını kurtarabilen bir uygulama iken, yanlış şekilde uygulandığında veya kateter bakımının yetersiz olduğu durumlarda flebit, infiltrasyon, ekstravazasyon, kanama, hematom, emboli, enfeksiyon gibi ciddi lokal ve sistematik komplikasyonlara neden olmaktadır. Bu komplikasyonlar arasında yer alan flebit, venin tunika intima tabakasının inflamasyonu olup, intravenöz tedavi uygulamalarında sık görülen ve önlenebilir bir komplikasyondur. Gelişen komplikasyonlar nedeniyle PVK'lerin zamanından önce çıkarılma oranı %70'lere ulaşabilmektedir. Yapılan çalışmalarda; ileri yaş, PVK uygulamalarında aseptik koşullara dikkat edilmemesi, hastaya uygulanan ilaç sayısı ve ilaç uygulama sıklığının fazla olması, asit-alkali sıvı ve asit-alkali ilaçların uygulanması, ilaç uygulamalarında hızlı infüzyon, sürekli infüzyon ve bolus yöntemiyle ilaç uygulamasının flebit gelişme riskini artırdığı; bununla beraber vialon kateterlerin ve 20-22 numaralı kateter kullanımının, PVK'nin sefalik, bazilik ve antekübital bölge venlerine uygulamasının flebit gelişme riskini azalttığı ve rutin kateter değişiminin flebit gelişme riskini etkilemediği belirlenmiştir. Ayrıca kateterin cilde sabitlenmesi, kateter uygulayan kişinin bilgi ve beceri düzeyi, set değişim süreleri gibi faktörlerin flebit gelişimini etkilediği tespit edilmiştir. Bu derlemede, periferik venöz katetere bağlı flebit gelişiminin önlenmesine yönelik kanıta dayalı hemşirelik uygulamaları açıklanmıştır.

Anahtar Kelimeler: Periferik venöz kateter; flebit; hemşirelik; kanıta dayalı hemşirelik uygulamaları
ABSTRACT
Peripheral venous catheterization (PVC), which is the process of inserting a cannula into the vessel lumen through the patient's skin, is one of the most frequently applied invasive nursing interventions in hospitalized patients. While PVC is a useful application that can save the life of the patient when applied correctly, it causes serious local and systemic complications (phlebitis, infiltration, extravasation, bleeding, hematoma etc.) when applied incorrectly or when catheter care is insufficient. Among these complications, phlebitis is inflammation of the tunica intima layers of the vein and is a common and preventable localization in intravenous examination procedures. Due to the developing difficulties, the premature removal rate of PVCs can reach 70%. Studies have shown that factors such as advanced age, not paying attention to aseptic conditions in PVC applications, number of drugs administered to the patient and frequency of drug administration, administration of acid-alkaline liquids/drugs, some methods used in drug administration (rapid infusion, continuous infusion and bolus method)' etc. increase the risk of developing phlebitis. However, in related studies, it has been determined that use of vialon catheters and number 20-22 catheter and application of PVC to cephalic, basilic and antecubital region veins reduce the risk of developing phlebitis and that routine catheter replacement does not affect the risk of developing phlebitis. Also, it has been confirmed that factors such as fixation of catheter to skin, knowledge and skill level of person applying catheter, and set change over times affect development of phlebitis. In this review, it is explained that evidence-based nursing practices for the prevention of peripheral venous catheter-related phlebitis.

Keywords: Peripheral venous catheter; phlebitis; nursing; evidence-based nursing practice
REFERENCES:
  1. Kuş B, Büyükyılmaz F. Görsel infüzyon flebit tanılama skalası: bağımsız gözlemciler arası uyum çalışması [Visual infusion phlebitis assessment scale: study of ındependent ınter-observer compliance]. Florence Nightingale Hemşirelik Dergisi. 2018;26(3):179-86. [Link] 
  2. Erdoğan BC, Denat Y. The development of phlebitis and ınfiltration inpatients with peripheral ıntravenous catheters in the neurosurgery clinic and affecting factors. International Journal of Caring Sciences. 2016;9(2):619-29. [Link] 
  3. Craven FR, Hirnle JC, Jensen S, eds. Uysal N, Çakırcalı E, çeviri editörleri. Hemşirelik Esasları İnsan Sağlığı ve Fonksiyonları. 7. Baskı. Ankara: Palme Yayıncılık; 2013. p.464-87.
  4. Ünal S. Ulusal Damar Erişimi Yönetimi Rehberi (UDEYR). Hastane İnfeksiyonları Dergisi. 2019;23(1):1-54. [Link] 
  5. Keogh S, Mathew S. Peripheral intravenous catheters: a review of guidelines and research. Australian commission on safety and quality in health care. Australian Commission on Safety and Quality in Health Care. 2019:9-37. [Link] 
  6. Mihala G, Ray-Barruel G, Chopra V, Webster J, Wallis M, Marsh N, et al. Phlebitis signs and symptoms with peripheral ıntravenous catheters: ıncidence and correlation study. J Infus Nurs. 2018;41(4):260-3. [Crossref]  [PubMed] 
  7. Carroll H, Bennett S. Guideline: peripheral intravenous catheter (PIVC). Queensland government. 2015
  8. Centers for Disease Control and Prevention [Internet]. [Cited: December 15, 2021]. Intravascular Catheter-related Infection (BSI). Available from: [Link] 
  9. Sağlık bakanlığı (2010) Hemşirelik yönetmeliği. (Erişim tarihi: 28.12.2021). Erişim linki: [Link] 
  10. Gorski LA. The 2016 Infusion Therapy Standards of Practice. Home Healthc Now. 2017;35(1):10-8. [Crossref]  [PubMed] 
  11. Phillips DL, Gorski L. Complications of infusion therapy: peripheral and central vascular access devices. Manual of I.V. Therapeutics, Evidence-Based Practice for Infusion Therapy. 6th ed. Philadelphia: F.A. Davis Company; 2014. p.541-61.
  12. Gorski LA, Hadaway L, Hagle ME, Broadhurst D, Clare S, Kleidon T, et al. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021;44(1S Suppl 1):S1-S224. [Crossref]  [PubMed] 
  13. Beccaria LM, Contrin LM, Werneck AL, Machado BD, Sanches EB. Incidence of phlebitis in adult patients [Incidência de flebites em pacientes adultos]. Journal of Nursing UFPE on line. 2018;12(3):745-52. [Crossref] 
  14. Potter PA, Perry AG, Stockert PA, Hall AM. Fundamentals of Nursing. 8nd ed. Canada: Mosby an Imprint of Elsevier Inc.; 2013. p.908-11.
  15. Cooper AS. Clinically indicated replacement versus routine replacement of peripheral venous catheters. Crit Care Nurse. 2019;39(4):67-8. [Crossref]  [PubMed] 
  16. Gorski LA. The 2016 infusion therapy standards of practice. Home Healthc Now. 2017;35(1):10-8. [Crossref]  [PubMed] 
  17. Infusion Nurses Society. Infusion nursing standards of practice. Journal of Infusion Nursing. 2011;34(1):57. [Link] 
  18. Infusion Nurses Society. Infusion Nursing Standards of Practice. J Infus Nurs. 2006;29(1 Suppl):S1-92. [Crossref]  [PubMed] 
  19. Uzun Ş. İntravenöz sıvı tedavisi. Aştı TA, Karadağ A, editörler. Hemşirelik Esasları Hemşirelik Bilimi ve Sanatı. 1. Baskı. İstanbul: Akademi Basın ve Yayıncılık; 2012. p.812-46.
  20. Furlan MDS, Lima AFC. Evaluation of phlebitis adverse event occurrence in patients of a Clinical Inpatient Unit. Rev Esc Enferm USP. 2021;55:e03755. Portuguese, English. [Crossref]  [PubMed] 
  21. Göktepe N. İntravenöz tedavi [Intravenous therapy]. Hemşirelikte Eğitim ve Araştırma Dergisi. 2004;1:20-7. [Link] 
  22. Alexandrou E, Ray-Barruel G, Carr PJ, Frost SA, Inwood S, Higgins N, et al; OMG Study Group. Use of short peripheral intravenous catheters: characteristics, management, and outcomes worldwide. J Hosp Med. 2018;13(5). [Crossref]  [PubMed] 
  23. Urbanetto Jde S, Peixoto CG, May TA. Incidence of phlebitis associated with the use of peripheral IV catheter and following catheter removal. Rev Lat Am Enfermagem. 2016;24:e2746. [Crossref]  [PubMed]  [PMC] 
  24. González López JL, Arribi Vilela A, Fernández del Palacio E, Olivares Corral J, Benedicto Martí C, Herrera Portal P. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-26. [Crossref]  [PubMed] 
  25. Uslusoy E, Mete S. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study. J Am Acad Nurse Pract. 2008;20(4):172-80. [Crossref]  [PubMed] 
  26. Tosun B, Kılıç Arslan B, Özen N. Periferik venöz kateter kaynaklı flebit gelişme durumu ve hemşirelerin kanıta dayalı uygulamalara ilişkin bilgi düzeyleri: Nokta prevalans çalışması [Phlebitis associated with peripheric venous catheter development and knowledge of nurses on evidence- based practices: point prevalence study]. Türkiye Klinikleri Hemşirelik Bilimleri Dergisi. 2020;12(1):72-82. [Crossref] 
  27. Berşe S, Tosun B, Tosun N. Periferik intravenöz katetere bağlı flebit oranının ve etkileyen faktörlerin değerlendirilmesi [Assessment of incidence of phlebitis associated with peripheric intravenous catheter and affecting factors]. Dokuz Eylül Hemşirelik Elektronik Dergisi. 2020;13(3):160-9. [Crossref] 
  28. Webster J, McGrail M, Marsh N, Wallis MC, Ray-Barruel G, Rickard CM. Postinfusion phlebitis: incidence and risk factors. Nurs Res Pract. 2015;2015:691934. [Crossref]  [PubMed]  [PMC] 
  29. Urbanetto JS, Muniz FOM, Silva RMD, Freitas APC, Oliveira APR, Santos JCRD. Incidence of phlebitis and post-infusion phlebitis in hospitalised adults. Rev Gaucha Enferm. 2017;38(2):e58793. Portuguese, English. [Crossref]  [PubMed] 
  30. Abadi P, Etemadi S, Abed Saeedi ZH. İnvestigating role of mechanical and chemical factors in the creation of peripheral vein in flammarion in hospitalization patients in hospital in Zahedan İran. Life Science Jornal. 2013;10(1):379-83. [Link] 
  31. Berman A, Snyder SJ, Frandsen G. Kozier & Erb's Fundamentals of Nursing: Conceps, Process and Practice. 10th ed. England: Pearson Education Limited; 2016. p.1363-83.
  32. Do Rego Furtado LC. Incidence and predisposing factors of phlebitis in a surgery department. British Journal of Nursing.2011;20(7):16-25. [Crossref]  [PubMed] 
  33. Mattox EA. Complications of peripheral venous access devices: prevention, detection, and recovery strategies. Crit Care Nurse. 2017;37(2):e1-e14. [Crossref]  [PubMed] 
  34. Mandal A, Raghu K. Study on incidence of phlebitis following the use of pherpheral intravenous catheter. J Family Med Prim Care. 2019;8(9):2827-31. [Crossref]  [PubMed]  [PMC] 
  35. Lind J, Danski MTR, Lenzi L, Pedrolo E, Schwanke AA, Johann DA. Peripheral catheter with closed infusion system: technology implementatıon. Journal of Nursing UFPE Online. 2019;13(5):1208-15. [Link] 
  36. Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs. 2015;38(3):189-203. [Crossref]  [PubMed] 
  37. Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A, et al, UK Department of Health. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2014;86 Suppl 1:S1-70. [Crossref]  [PubMed]  [PMC] 
  38. Gupta A, Mehta Y, Juneja R, Trehan N. The effect of cannula material on the incidence of peripheral venous thrombophlebitis. Anaesthesia. 2007;62(11):1139-42. [Crossref]  [PubMed] 
  39. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-93. [Crossref]  [PubMed]  [PMC] 
  40. Dychter SS, Gold DA, Carson D, Haller M. Intravenous therapy: a review of complications and economic considerations of peripheral access. J Infus Nurs. 2012;35(2):84-91. [Crossref]  [PubMed] 
  41. Wallis MC, McGrail M, Webster J, Marsh N, Gowardman J, Playford EG, et al. Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial. Infect Control Hosp Epidemiol. 2014;35(1):63-8. [Crossref]  [PubMed] 
  42. Carballo M, Llinas M, Feijoo M. Flebitis en catéteres periféricos (y II). Un estudio [Phlebitis in peripheral catheters (II). A study]. Rev Enferm. 2004;27(9):34-8. Spanish. [PubMed] 
  43. Regueiro Pose MA, Souto Rodríguez B, Iglesias Maroño M, Outón Fernández I, Cambeiro Nuñez J, Pértega Díaz S, et al. Catéteres venosos periféricos. Incidencia de flebitis y sus factores determinantes [Peripheral venous catheters: incidence of phlebitis and its determining factors]. Rev Enferm. 2005;28(10):21-8. Spanish. [PubMed] 
  44. Stevens C, Milner KA, Trudeau J. Routine versus clinically ındicated short peripheral catheter replacement: an evidence-based practice project. J Infus Nurs. 2018;41(3):198-204. [Crossref]  [PubMed] 
  45. Chang WP, Peng YX. Occurrence of phlebitis: a systematic review and meta-analysis. Nurs Res. 2018;67(3):252-60. [Crossref]  [PubMed] 
  46. Lu Y, Hao C, He W, Tang C, Shao Z. Experimental research on preventing mechanical phlebitis arising from indwelling needles in intravenous therapy by external application of mirabilite. Exp Ther Med. 2018;15(1):276-82. [PubMed]  [PMC] 
  47. Pasalioglu KB, Kaya H. Catheter indwell time and phlebitis development during peripheral intravenous catheter administration. Pak J Med Sci. 2014;30(4):725-30. [Crossref]  [PubMed]  [PMC] 
  48. Ünal S. Damar içi kateter infeksiyonlarının önlenmesi klavuzu. Hastane İnfeksiyonları Dergisi. 2013;17(2):233-79. [Link] 
  49. Capdevila J, Guembe M, Barberán J, Alarcón A, Bouza E, Farinas MC, et al. Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adults. Cir Cardiov. 2016;23(4):192-8. [Link] 
  50. Salgueiro Oliveira A, Parreira P, Veiga P. Incidence of phlebitis in patients with peripheral intravenous catheters: the influence of some risk factors. Australian Journal of Advanced Nursing. 2012;30(2):32-9. [Link] 
  51. Cicolini G, Manzoli L, Simonetti V, Flacco ME, Comparcini D, Capasso L, et al. Phlebitis risk varies by peripheral venous catheter site and increases after 96 hours: a large multi-centre prospective study. J Adv Nurs. 2014;70(11):2539-49. [Crossref] 
  52. Nickel B. Peripheral intravenous access: applying ınfusion therapy standards of practice to ımprove patient safety. Crit Care Nurse. 2019;39(1):61-71. [Crossref]  [PubMed] 
  53. Bernatchez SF. Care of peripheral venous catheter sites: advantages of transparent film dressings over tape and gauze. JAVA. 2014;19(4):256-61. [Link] 
  54. Simin D, Milutinović D, Turkulov V, Brkić S. Incidence, severity and risk factors of peripheral intravenous cannula-induced complications: An observational prospective study. J Clin Nurs. 2019;28(9-10):1585-99. [Crossref]  [PubMed] 
  55. Ford C. Cannulation in adults. Br J Nurs. 2019;28(13):838-41. [Crossref]  [PubMed] 
  56. Marucci F, Baretta A, Yasuoka M. Chamomılla recommended use as treatment and prevention of flebite in patients with cacer: literature review. World Journal of Pharmacy and Pharmaceutıcal Sciences. 2018;7(9):220-7. [Link] 
  57. Gorski LA, Hagle ME, Bierman S. Intermittently delivered IV medication and pH: reevaluating the evidence. J Infus Nurs. 2015;38(1):27-46. [Crossref]  [PubMed] 
  58. Macklin D. Phlebitis: A painful complication of peripheral IV catheterization that may be prevented. American Journal of Nursing. 2003;103(2):55-60. [Crossref]  [PubMed] 
  59. Higginson R, Parry A. Phlebitis: treatment, care and prevention. Nurs Times. 2011;107(36):18-21. [PubMed] 
  60. Curran ET, Coia JE, Gilmour H, McNamee S, Hood J. Multi-centre research surveillance project to reduce infections/phlebitis associated with peripheral vascular catheters. J Hosp Infect. 2000;46(3):194-202. [Crossref]  [PubMed] 
  61. Webster J, Osborne S, Rickard CM, New K. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2015;(8):CD007798. Update in: Cochrane Database Syst Rev. 2019;1:CD007798. [Crossref]  [PubMed] 
  62. Purssell E. Preventing infection in intravenous catheters in the community. Br J Community Nurs. 2017;22(8):374-7. [Crossref]  [PubMed] 
  63. Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010;33(6):371-84. [Crossref]  [PubMed] 
  64. Delp J, Hadaway L. New product decisions-the process and out come for a community health system. The Journal of the Association for Vascular Access. 2011;16(2):78-9. [Crossref] 
  65. Jackson A. Retrospective comparative auditof two peripheral IV securement dressings. British Journal of Nursing. 2012;21(1):10-5. [Link] 

.: Up To Date

.: Process List

Login



Contact


Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com